Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,06 USD | 0,00% | -9,40% | +22,54% |
Omzet 2024 * | 147 mln. 137 mln. | Omzet 2025 * | 165 mln. 154 mln. | Marktkapitalisatie | 123 mln. 115 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -146 mln. -137 mln. | Nettowinst (verlies) 2025 * | -182 mln. -170 mln. | EV/omzet 2024 * | 1,35 x |
Nettoschuld 2024 * | 74 mln. 69,21 mln. | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,75 x |
K/w-verhouding 2024 * |
-0,87
x | K/w-verhouding 2025 * |
-1,01
x | Werknemers | 325 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 95,59% |
Recentste transcriptie over Karyopharm Therapeutics Inc.
1 week | -9,40% | ||
Lopende maand | -29,80% | ||
1 maand | -23,74% | ||
3 maanden | +16,98% | ||
6 maanden | +32,30% | ||
Lopend jaar | +22,54% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 56 | 26-02-20 |
Mike Mason
DFI | Director of Finance/CFO | 49 | 25-02-19 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 01-04-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Garen Bohlin
BRD | Director/Board Member | 76 | 03-10-13 |
Barry Greene
BRD | Director/Board Member | 60 | 01-01-13 |
Director/Board Member | 59 | 01-04-13 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.04% | 0 M€ | 0,00% | - | |
0.02% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 1,06 | 0,00% | 657 825 |
25-04-24 | 1,06 | -2,75% | 644 718 |
24-04-24 | 1,09 | 0,00% | 1 204 243 |
23-04-24 | 1,09 | -3,54% | 1 591 093 |
22-04-24 | 1,13 | -3,42% | 791 015 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+22,54% | 123 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,71 mld. | |
+1,69% | 22,02 mld. | |
-17,37% | 20,9 mld. | |
-9,30% | 17,85 mld. | |
-41,01% | 16,21 mld. | |
-14,85% | 15,52 mld. | |
+3,21% | 13,86 mld. | |
+33,54% | 12,04 mld. |